USDA to overhaul regulatory process for biotech crops to incorporate advances in gene editing

Molecular Scissors

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

. . . . Improved techniques for altering crop genomes are already bringing a new generation of plant varieties to the market — and around the world, regulators are playing catch-up.

. . . .

On 18 April, the US National Academies of Sciences, Engineering and Medicine will begin its first meeting of a committee charged with ending the struggle. The committee, which is sponsored by the US Department of Agriculture (USDA) and two other agencies, has been asked to predict what advances will be made in biotechnology products over the next 5–10 years. It is scheduled to report by the end of the year on the steps that regulators need to take to prepare themselves. The result could inform an ongoing USDA effort to re-assess its process for evaluating engineered crops.

. . . .

Many feel that regulations in the United States, which grows more GM crops than any other country, are particularly ripe for change. The USDA itself has acknowledged that it might be over-regulating some crops if they have traits that have already been scrutinized. . . .

. . . .Over the past five years, the USDA has determined that about 30 types of GM plant — from soya beans whose oil has a longer shelf life, to pineapples with rose-coloured flesh — do not fall under its regulatory rubric. Some were made using gene-editing techniques.

“One of the things that has to happen is to plug that huge hole,” says Doug Gurian-Sherman, director of sustainable agriculture at the Center for Food Safety, an environmental-advocacy group in Washington DC. “Whether you think they’re over-regulated or under-regulated or just not intelligently regulated, there’s nobody who thinks this is appropriate.”

Read full, original post: Gene-editing surge drives US to rethink regulations

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot 2026-05-26 at 10.15
Viewpoint: Double standard—Why does the wellness industry get a free pass while Big Healthcare is treated as morally suspect?
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot 2025-07-30 at 10.48
Can gene editing eliminate Down syndrome? Scientists have done it in lab-grown cells
tick-DNA
GLP podcast: Spread meat allergy with gene-edited ticks? Bioethicists pose vile ‘thought experiment’
ChatGPT-Image-Jun-4-2026-01_27_58-PM
Viewpoint—N.A.D.+: Why Gwenyth Paltrow’s heralded anti-aging supplement doesn’t work
downsyndrome_compilation_MID_1
CRISPR breakthrough that can remove the chromosome responsible for Down syndrome raises ethical questions
Screenshot-2026-06-03-at-1.24.46-PM
Challenging anti-GMO disinformation: Why genetically-tweaked crops offer bushels of benefits
ChatGPT-Image-Jun-4-2026-11_49_36-AM-2
‘You don’t understand Tolkien’: Skeptic Pope trolls tech giants about the exaggerated, risk-less benefits of AI
ChatGPT-Image-May-26-2026-07_51_21-AM-2
Viewpoint: There are more than 1,000 chemicals in a cup of coffee—including many substances that can cause cancer. Why isn’t it banned?
Screenshot-2026-06-04-at-12.05.08-PM
Cases of brain inflammation surge as U.S. measles pandemic approaches 2000

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.